NR4A1 and colonic neoplasm: Moreover, we have also reported that this compound also inhibited tumor growth in a syngeneic mouse model of colon cancer using MC-38 cells as xenografts and the analysis of T cells in tumor-infiltrating lymphocytes showed that the dual NR4A1/2 ligands reversed T-cell exhaustion [51].